We have studied several monoclonal anti-double-stranded (ds) DNA antibodies for their ability to accelerate lupus nephritis in young NZB X NZW Fl female mice and to induce it in BALB/c mice. Two identified as pathogens in both strains have characteristics previously associated with nephritogenicity: expression of IgG2a isotype and IdGN2 idiotype. Both pathogenic antibodies used the combination of genes from the VHJ558 and VK9 subfamilies. Two weak pathogens failed to accelerate nephritis in young BW mice, but induced lupus nephritis in BALB/c mice. They both express IdGN2; one is cationic and an IgG3, the other is an IgG2a. Additional MAbs (some IgG2a, one IdGN2-positive) did not accelerate or induce nephritis. We have cloned and sequenced the variable regions of the immunoglobulin genes of one pathogenic autoantibody. No unique V, D, or J gene segments and no evidence of unusual mechanisms in generating diversity were used to construct this antibody. These data argue against use of unique abnormal Ig genes by systemic lupus erythematosus individuals to construct pathogenic autoantibody subsets. Instead, the major abnormality may be immunoregulatory. (J. Clin. Invest. 1990. 85:530-540.) immunoglobulin gene * pathogenic autoantibody * systemic lupus erythematosus
Introduction
In several autoimmune diseases such as systemic lupus erythematosus (SLE),' tissue damage is caused at least in part by autoantibodies and immune complexes containing autoantibodies (reviewed in reference 1). Therefore, there has been great interest in determining whether autoantibodies are derived from unique immunoglobulin (Ig) germline genes, and/ or unique rearrangements of those genes, or, alternatively, are from somatic (hyper)mutation of antibodies originally directed against foreign antigens. To date, most data have suggested that few, if any, unique features characterize the Ig genes coding for autoantibody repertoires (reviewed in refer-ences 2 and 3). Limited sequence information has shown that both germline genes and somatically mutated genes can encode autoantibodies in SLE (4) (5) (6) (7) (8) (9) . In some cases, the same or similar variable region rearrangements of heavy (H) and light (L) chain can be used in antibodies binding exogenous or autologous antigens (6) (7) (8) (10) (11) (12) .
Not all autoantibodies are pathogenic. Antibodies reactive with self are part of normal immune repertoires. Individuals with autoimmune diseases such as SLE have the ability to make pathogenic subsets of autoantibodies, and the inability to down-regulate them. NZB X NZW F1 female (BW) mice have been used as models of SLE nephritis which is caused at least in part by antibodies to DNA (13, 14) . In studies ofwhole autoantibody populations in murine and human lupus, there have been conflicting data regarding the characteristics of pathogenic, nephritogenic subsets. It is generally agreed that IgG antibodies to DNA, particularly IgG isotypes that fix complement well (IgG2a, 2b, and 3 in mice), are highly associated with clinical nephritis (15) (16) (17) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) .
Several investigators have suggested that certain public idiotypes can serve as markers for pathogenic antibody subsets (23, [27] [28] [29] . These opinions have been based on (a) identification of the idiotypes on Ig deposited in tissue lesions, including glomeruli, (b) delay of clinical nephritis by in vivo suppression of certain idiotypes (27, 30, 31) , and (c) induction of lupus-like antibodies and nephritis in several normal mouse strains by in vivo up-regulation of an idiotype characteristic of human SLE (32-34). For example, we have suggested that in the BW mouse, IdGN2-positive IgG is enriched in pathogenic autoantibodies, whereas IdX-positive IgG is not. IdGN2 together with IdGN1 accounts for -50% ofthe Ig deposited in glomeruli of nephritic BW mice; IdX for < 5% (27) . IdGN2 is found more frequently than other idiotypes in the glomeruli of patients with lupus nephritis, and is infrequent in glomeruli of patients with non-lupus immune glomerulonephritis (35) . Down-regulation of IdGN 1 and IdGN2 is associated with delayed onset of nephritis in BW mice (27, 31) . Whether the ability to make these pathogenic subsets results from genetic information unique to individuals with SLE, from immunoregulatory disorders, or from both, is unclear.
and L chains of one of the pathogenic antibodies has been completed. Matches Isoelectric focusing. Each MAb was analyzed for pI by methods previously described (38) .
ELISA assayfor binding ofDNA. Binding of MAbs to dsDNA was determined in an ELISA assay as described elsewhere (36 The ELISA assay for identification of these Ids on MAbs was performed as described previously (36) , with MAb anti-DNA coated on polyvinyl plates followed by incubation with alkaline-phosphatase labeled anti-Ids. MAbs (35) . Slides were interpreted for the presence and the intensity of fluorescence in glomeruli by a blinded observer. Individual glomeruli in each section were graded from 0 to 3+, with 0 representing no glomerular fluorescence above background and 3+ representing bright fluorescence.
To determine whether the pathogen A6. 1 was deposited directly in glomeruli of BW mice, two MAbs (A6. 1 and IGE6 negative control) were radiolabeled with 125I as previously described (39) . Then, groups of six BW female mice (pretreated with iodine to block thyroid uptake of '25I) were inoculated once with either radiolabeled A6. 1 or IGE6 as follows: group 1, inoculated at age 21 wk without other treatment; group 2, inoculated at age 22 wk after I wk of daily injections with 200 Mg of unlabeled MAb. In previous studies (39, 40) we showed that virtually any radiolabeled MAb anti-DNA adheres to glomeruli of lupus mice 6 h after injection, but little remains at 24 h. Therefore, mice were killed 24 h after administration of the radiolabeled MAb. ,y-Emissions were determined in whole liver, spleen, and kidneys from each animal. Then, glomeruli were isolated from both kidneys by methods previously described (27) and extensively washed in PBS, pH 7.2. The y emissions from all glomeruli of each mouse were determined in a y-counter (Beckman Instruments, Inc., Palo Alto, CA), and results were expressed as counts per minute per gram of renal tissue.
Cloning of immunoglobulin genes of hybridoma A6.1. Bacteriophage A Jl (41) was a kind gift from Dr. Mitchell Kronenberg, University of California, Los Angeles. Phage DNAwnas digested with Hind III and ligated with size-fractionated Hind III digested A6.1 DNA (9-14 kb). The ligation mixture was packaged using Gigapack Plus (Stratagene, La Jolla, CA) and 1.2 million recombinant phages were grown on the P2392 strain of bacteria. Probe preparations and hybridization conditions were as described (42, 43) . The 2.0-kb Bam H-EcoRI restriction fragment containing the germline JH3-JH4 region was used as a JH probe, and the 1.7-kb Hind III-Bgl II fragment containing JKI-JK5 germline region was used as a JK probe. JH-and JK-positive clones were identified by positive signals from autoradiograms of duplicate filters.
RNA preparation and Northern blots. Total RNA from A6.1 cells was prepared (44), and polyA+ RNA was selected by oligo(dT)-cellulose chromatography (45) . 2 ug of polyA+ RNA from A6.1 was electrophoresed in a formaldehyde gel, blotted, and probed as described (46) .
Sequencing of VH and VK ofgenes ofA6.1. The 1.9-kb XbaI fragment from JH positive phage was isolated, digested with Pvu II and the resulting Xba I-Pvu II and Pvu II-Xba I fiagments were subcloned into the Sma I site of the plasmid bluescript (Stratagene) in both orientations. The sequence ofthe VHA6.1 region was determined from coding and noncoding strands with universal and reverse primers by dideoxynucleotide chain termination (47) using a Sequenase kit from United States Biochemicals, Cleveland, OH.
For the VKA6.1 region, a 7-kb Xba I fragment was isolated from JK positive phage and cloned into the Xba I site of plasmid bluescript. The sequence of VKA6.1 region was determined using the Sequenase kit with antisense primers of 5' CK (corresponding to codons 116-122). This sequence was confirmed by a sense primer (5'-GCTTGGTCCCCCCTCCG) of the 5' leader region. All primers used in this study were synthesized by Dr. Dohn Glitz ofthe Department of Biological Chemistry, University of California, Los Angeles.
Results
MAbs studied. Characteristics of the MAbs studied are shown in Table I . Six different IgG2a and 2b MAb anti-DNAs from nephritic BW mice were included as potential pathogens. Five additional MAbs included those from BW or other strains that were IgM, IgGl, IgG3, or non-DNA binding.
Evidence that certain MAbs are pathogenic and accelerate nephritis. Results of in vivo administration of anti-DNA-producing hybridoma B cells or purified MAbs to BW and C57B1/6J mice are shown in Table II ; results in BALB/c mice are shown in Table III . In BW mice, significant increases in the proportions of mice with clinical nephritis occurred at 25 wk of age for two MAbs, A6. 1 and 3GB3. Those MAbs produced proteinuria and azotemia in 78-86% of BW mice compared with 22% ofcontrol mice at that time. Mice receiving A6. 1 had significant increases in nephritis (100% vs. 76% of controls) at 30 wk of age; 3GB3 and BWds3 also produced nephritis in 100% of mice by that time; the differences were not significant. The A6. 1 and 3GB3 MAbs share the following characteristics: IgG2a, expression ofboth IdGN2 and IdX, binding to dsDNA, and usage of gene subfamilies VHJ558 and VK9.
Two IdGN2+ MAbs (BWdsl and BWds3) increased the frequency of BW mice with nephritis at 25 wk (46-47% vs. 22% of controls), however, the differences were of borderline significance (0.05 < P < 0.1).
Several MAbs did not accelerate nephritis (IGF2, 4GH 1 1, 5GD5, 1GE6). 1GF2, 1GE6, and 4GHl 1 differ from IgG2 pathogens in that they do not express IdGN2. 5GD5 expresses IdGN2 and is IgG2a. Pathogenicity had no obvious relationship to estimated binding affinity to DNA. As shown in Table I the amounts ofpurified antibody to achieve 50% binding of40 ng of DNA were 10 Aig for the nonpathogenic antibody 5GD5, and 10 and 100 Mg for the pathogenic antibodies A6.1 and 3GB3, respectively.
As shown in Table III , the two pathogens (A6. 1 and 3GB3) defined in young BW mice also induced proteinuria and azotemia in BALB/c mice. [1] [2] [3] [4] * As a result of this study, these antibodies are considered definite pathogens in that they accelerate nephritis in BW mice. t As a result of this study, these MAbs are considered weak pathogens; they did not accelerate nephritis in BW mice but did induce it in BALB/c mice. I As a result of a study done by the investigators who derived this MAb, it is judged to be a nonpathogen (52 ogens in BW mice (I GE6, 5GD5, and 4GHI 1) were nonpathogens in the BALB/c strain. Therefore, the analyses of definite pathogens and nonpathogens were similar in the BW mice (donors of the MAbs) and the unrelated, normal BALB/c strain. In contrast to BALB/c mice, C57B1/6J mice did not develop nephritis after 8 wk ofrepeated administration ofA6. 1 (Table II) . In BW mice, renal damage was estimated on a scale from 0 to 3+ by examining hematoxylin-eosin-stained tissue from seven mice in the negative control group and five in the groups treated with pathogenic MAbs. Significant differences between these two groups in mean tissue damage were found; see Table  IV A. When mice receiving A6. 1 were compared to the negative controls, differences were also significant (P < 0.05).
Since the renal damage noted clinically and pathologically could have been due to deposition of Ig other than that inoculated, frozen kidney sections from BW mice receiving no treatment, or receiving hybridoma cells that secreted antibodies of interest were examined for deposition of IdGN2. If nephritis were caused by deposition of anti-Id, or up-regula- significant difference was found comparing the amount of IdGN2 in glomeruli in BW mice receiving 4GH 11 to that in either control group. Glomeruli of BALB/c mice were assessed by indirect immunofluorescence for the expression ofIdGN2. We previously demonstrated that IdGN2 is not expressed in sera of BALB/c mice (27) . As shown in Table V, A6.1 hybridoma-bearing BALB/c mice had significantly higher (P < 0.001) IdGN2-positive Ig deposited in glomeruli than did BALB/c mice either untreated or inoculated with myeloma MOPC21 or hybridoma IGE6. The simplest explanation for the presence of IdGN2 in glomeruli ofBALB/c mice is the direct deposition of IdGN2-positive MAbs secreted by the injected hybridoma cells.
Deposition ofinjected antibody in glomeruli. The increased expression ofIdGN2 observed in glomeruli ofBW mice inoculated with A6. 1 cells could be due to (a) direct deposition of pathogenic MAb or (b) enhanced production of IdGN2 positive Ig of the host. To distinguish between these two possibilities, we followed the tissue distribution of injected '25I-labeled MAb. As shown in Table VI , repeated inoculations of the pathogenic MAb, A6. 1, resulted in deposition of large quantities in glomeruli. In contrast, repeated inoculations of the nonpathogenic MAb 1GE6 did not. The differences were seen both before and after 1 wk of repeated inoculations. Before injections A6.1 was found in significantly higher quantities than lGE6 in both kidneys and liver, suggesting it might be a "sticky antibody." However, after 1 wk of inoculations A6. 1 was present in whole kidneys in more than five times the quantities of 1GE6, and in glomeruli about threefold higher. However, quantities of the two MAbs deposited in liver were similar. These data suggest that the pathogenic MAb was deposited directly in glomeruli.
We conclude from these data that A6.1 is a pathogenic autoantibody which can accelerate nephritis in BW mice and induce it in BALB/c mice, probably by direct deposition in glomeruli.
Cloning ofpathogenic autoantibody A6.1. We obtained a genomic clone of A6.1 containing the variable regions of Ig genes. Southern analyses were performed on genomic DNA from BW liver, parental myeloma Sp2/0, and A6. 1 hybridoma cells to detect restriction fragments containing the rearranged V-(D)-J genes by hybridization to JH or JK probes. The expressed A6. 1 VH and VK genes were contained on unique 10-' and 12-kb Hind III fragments, respectively (data not shown). The expressed fragments were different in size from those derived from the germline liver sample and the rearranged myeloma SP2/0. Thus we isolated 9-14-kb Hind III digested genomic A6. 1 DNA to make a X bacteriophage library.
JH and JK positive clones were mapped with restriction sites; results are shown in Fig. 1 . A 1.9-kb Xba I fragment as depicted in Fig. 1 A was isolated from the JH-positive phage to probe a Northern blot containing A6. 1 RNA. Another strip with the same amount of A6. 1 RNA was probed with cDNA containing the IgG2b constant region which hybridized to both of the highly homologous IgG2a and IgG2b messages (48) . A common band -2.1 kb was found hybridizing to both probes as shown in Fig. 2 A. We have previously cloned a nonproductively rearranged VHDJH gene from A6.1 cells which did not hybridize to the polyA+ RNA from A6. 1 in this experiment (data not shown). Thus, the 1.9-kb Xba I fragment contains the VHDJH gene expressed by A6. 1. Similarly, Fig. 1 B from JK-positive phage separately. An RNA species of about 1.2 kb, the expected size of IgK messages, was detected by each probe (Fig. 2 B) . Thus, the 2.8-kb fragment contains the expressed VKJK of A6. 1. Sequencing ofthe VH region ofA6. 1. The 1.9-kb XbaI fragment of the expressed VH gene was subcloned and the sequence ofthe A6. 1 VH gene was determined as shown in Fig. 3 . The A6. 1 VH was a member of the largest VH subfamily, J558 (49), and was 98% homologous to the expressed VH of H130 (5) . The monoclonal H130 (IgM, K) binds ssDNA (50) and bears a dominant public Id of MRL/lpr mice (51) , a murine SLE model genetically-unrelated to BW mice. H 130 has been shown in another system to be nonnephritogenic (52). A6.1 and H 130 had differences in six nucleotides which resulted in four differences in amino acids scattered in the VH framework regions. The VH H 130 probably uses a germline gene in that its sequence is identical to the sequenced portion (amino acids 4-92) of a BALB/c germline J558 VH gene, H18 (53) . The sequences of D and JH4 segments of A6. 1 are homologous to the corresponding BALB/c germline sequences (54, 55) . At the VH-DH junction the sequence GATTCCCC, and at the D-JH junction sequence GGG could be generated by N region addition (56) . The Fig. 4 . They may have derived from the same germline VK9 gene. Hybridoma BXW-16 (IgM, K) secretes antibodies to ssDNA and is derived from a 6-mo-old BW mouse (1 1). It has not been tested for pathogenicity in any system; since it is an IgM it is unlikely that it can cause nephritis.' Both antibodies used the JK2 gene, thus the sequences of VK-JK regions of A6. 1 and BXW-16 were also 98% identical. Interestingly, the VH'ofBXW-16 is also derived from aJ558 subfamily with a 91% match to the VH ofA6. 1 (58, 59) . Until more mouse strains are tested with our pathogenic autoantibodies, we do not know whether MHClinked genes are involved in susceptibility. The pathogenicity of four different MAbs observed in normal BALB/c mice argues against the possibility that BW mice express an unique antigen in their kidneys. It is likely that the ability to produce a nephritogenic autoantibody subset is both necessary and sufficient to induce lupus nephritis in a susceptible genetic background.
The Ig genes encoding anti-DNA antibodies derived from mice predisposed to lupus, and from patients with the disease, have been studied by many investigators. Most genetic studies were carried out in lupus-prone mice, and no disease association was found with any particular IgH-or IgK-V haplotype (2, 3, 11) . Furthermore, no unique features of Ig gene repertoire have been detected: (a) restriction fragment length polymorphism studies of Ig heavy chain and kappa light chain loci of autoimmune mice reveal that both loci are inherited unaltered from their nonautoimmune ancestors (11, 60, 61) , (b) analyses of variable regions of Ig genes encoding antibodies to DNA demonstrate the same variable region families that are present in normal mice and are used to encode antibodies to foreign antigens (6, 10-12, 36, 62-64) . In agreement with these observations, we found no unique V, D, or J gene segments used in a pathogenic autoantibody. The sequence of VHA6.1 is 98% identical to the nonpathogenic VHH 130, and is > 90% identical to VH used by normal antibodies to alpha 1 --6 dextran (65). It is possible that pathogenic antibodies are derived from a unique germline subfamily of VHJ558. Interestingly, in lupus-prone BW and MRL/lpr mice, preferential usage of VHJ558 is observed as mice age (36, 66) , which could result from overexpression of all VHJ558 subfamilies or of selected subsets. Thus far we have ruled out two J558 subfamilies, p-azophenylarsenate A (67) and H4a-3 (68, 69), which are mapped proximally to D-J regions and have < 85% sequence homology to VHA6. 1.
Until the germline counterpart of VHA6.1 is cloned, we cannot directly address the role of somatic mutation in generating pathogenic autoantibody. Behar and Scharff (7) have cloned both NZB and NZW germline S107-VH 11 genes from which five BW anti-DNA MAbs derived their VH genes. Comparing R/S ratios in complementarity determining regions and frameworks they concluded the extent of somatic mutations is similar to those observed in BALB/c antibodies elicited by influenza virus which use the germline S 107-VH 11 gene (7). The nucleotide sequences of the S107-VH 1 gene from NZB and NZW mice are identical, 8 of 290 nucleotides in the mature coding region are polymorphic in the BALB/c germline gene. The six-nucleotide difference of VHA6.1 and BALB/c germline VHH 18 gene may be partially due to polymorphism; the high degree of sequence match makes it less likely that somatic hypermutation is the mechanism of generating this pathogenic autoantibody.
The VKA6.1 sequence is most similar to VK BXW-16 (98%), the next best match is to the VK region of an anti-lysozyme antibody (88%) (70) . It is interesting to note the bestmatched VH and VK genes to V genes ofA6. 1 are both found in antibodies to DNA derived from lupus mice, suggesting that common mechanisms cause the expansion of these B cell clones.
Comparison of VH sequence homology between A6. 1 and 8 other published antibodies to DNA derived from lupus mice using VHJ558 shows considerable heterogeneity (78-98% match), similar to that observed in antibodies to various antigens (5, 8, (10) (11) (12) (four nearly identical VH sequences encoding clonally related MAbs are considered as one from reference 8). At least five D genes and all four JH segments are used to encode murine antibodies to DNA with various numbers (5-16) of amino acids in the CDR3 region. Besides BXW-16, none of the other 13 anti-DNA antibodies (8, 11, 12) sequenced use the VK9 gene. Thus, there is considerable structural diversity in generating binding sites for DNA.
There are similarities among anti-DNA MAbs. The predicted amino acid sequences of the CDR3 region of A6.1 contain a motif of YYGSS; remarkably similar motifs are also found in three murine (U4, BXW-7, BXW-16) and three human (18/2, 21/28, TH3, Kim4.6) anti-DNA antibodies (6, 11, 71, 72) . This motif may be important in IdGN2 expression, since it is present in IdGN2+ A6.1 and BXW-16 but absent in IdGN2-H 130. IdGN2 is a conformational idiotype, its expression relies on both chains of Ig. In our library of anti-DNA MAbs 10/11 IdGN2 expressing hybridomas use VHJ558 with four VK subfamilies (30, and Table I ). We are in the process of sequencing the expressed V regions of the other IdGN2+ MAbs attempting to define the structural basis of the idiotope.
In one computer-modeled three-dimensional anti-ssDNA antibody structure, the antigen-combining site is surrounded by all complementarity determining regions (CDR) except L2, resulting in lining both the walls and base of the cleft with a preponderance of arginine and tyrosine residues (12) . The D segment of A6.1 derived from the germline DFL-16 is using a reading frame which encodes four tyrosines. In addition, there is the fifth tyrosine in CDR3 encoded by JH4. There are three basic residues in CDR2, 1 and 5 tyrosines in CDRl and CDR3 of the heavy chain; and a total of three arginine residues in CDR1 and three of the light chains of A6. 1. These residues may participate in electrostatic and hydrogen bonding interactions with the sugar phosphate backbone of DNA.
The data in this paper show that no unique genetic components-i.e., V, D, or J gene segments-are used to comprise pathogenic autoantibodies since one can find evidence that the same elements are used in nonpathogenic and even normal antibodies. However, the data here and elsewhere are consistent with the possibility that particular combinations of common elements may lead to a pathogenic autoantibody. The occurrence of VHJ558 with a particular D and VK9 in pathogenic BW autoantibodies may be an example of such a "bad" combination. Similarly, the normal processes of N region addition and/or somatic mutation may generate pathogenic autoantibodies. Since current evidence suggests that formation of different combinations, N regions and somatic mutations appears to be random or nearly so, this argues that the defect in autoimmune mice is their inability to down-regulate the expression of these pathogenic combinations, which are generated by normal mechanisms.
